A woman identified as Jenny Mitchell from Missouri, USA has decided to file a lawsuit against the famous hair care brand L’Oréal because, according to the woman, the carcinogenic components of the products caused her cancer, it is why who couldn’t realize her dream of being a mother.
Four years ago, she was diagnosed with uterine cancer. the woman’s explanation for the terrible disease dates back to when she was in ninth grade, when she was already using the brand’s productsin particular the ORS care range (to smooth frizzy hair).
For this reason, the lawsuit was filed against L’Oréal, ORS, as well as three other manufacturers of hair straightening products. This is believed to be the first lawsuit filed under the relationship between the products’ components and cancer, according to Ben Crump, the plaintiff’s attorney.
The lawsuit considers the millions of dollars that have been generated in profits for the brands, in addition to the lack of clarity regarding the warnings the containers should have, alerting them to harmful chemical compounds.
Food and drug authorities in the United States have tightened controls and measures on the chemical composition of hair care products of different brands.
The personal care products giant Unilever announced the voluntary recall of a high number of lots corresponding to five brands of shampoo in the United States. The measure is taken after high levels of a carcinogen have been detected in the composition of the products.
The United States Food and Drug Administration (FDA) has noted that the recalled products are in the form of a dry shampoo spray and were manufactured before October 2021 by the brands Dove, Nexxus, Suave, TIGI (Rockaholic and Bed Head) and TRESemme.
According to the health authority, product recall due to potentially high levels of benzene.
“Benzene is classified as carcinogenic to humans. Exposure to benzene can occur by inhalation, through the mouth, and through the skin and can lead to cancers, such as leukemia and bone marrow blood cancer, as well as life-threatening blood disorders , the FDA said in a statement.
Adverse reactions or quality issues experienced with the use of these products may be reported to the Food and Drug Administration’s MedWatch Adverse Event Reporting program.
In addition, the list of references with their respective codes has been made public so that they can be perfectly identified by the consumer when purchasing hair products. According to the FDA, the use of such references should be avoided to avoid future health repercussions.
Biden against cancer
The president of the United States, Joe Biden issued an executive order in early September to promoting biotechnology through its Cancer Moonshot initiativewhich evokes the efforts to land a man on the Moon 60 years ago.
The president is pushing to coordinate and fund a fight against cancer, with the goal of halving death rates from the disease in the next 25 years.
The executive order provides federal support for “areas that will define America’s biotechnology leadership and our economic competitiveness for decades to come,” a senior Biden administration official told media.
He added that while US biotechnology research leads the world, industrial applications are multiplying in the hands of other countries.
“Unless we translate biotech innovation into social and economic benefits for all Americans, other countries, including and especially China, are aggressively investing in this sector,” which poses a “risk,” the manager said.
The White House assured that the biotechnology industry is at the forefront of medical advances, especially in the rapid development of vaccines, tests and treatments to help manage the covid-19 pandemic, but the scope of this potential goes much further.
*With information from AFP.